What does osimertinib mesylate tablets treat?

Osimertinib mesylate tablets are an anti-tumor drug mainly used to treat specific types of non-small cell lung cancer (NSCLC). Osimertinib mesylate tablets are mainly used to treat patients with epidermal growth factor receptor (EGFR) exon19 deletion or exon21 Adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with substitution mutations (L858R). These patients have usually been treated with other EGFR tyrosine kinase inhibitors (TKIs), have progressed, and have been tested to be positive for the EGFR T790M mutation.

Osimertinib mesylate tablets can specifically block EGFR signaling, thereby inhibiting the growth, proliferation and differentiation of non-small cell lung cancer cells and inducing cancer cell apoptosis. This mechanism of action makes osimertinib an important treatment option for patients with EGFRmutationsNSCLC.

Before treatment with Osimertinib Mesylate Tablets, it is recommended to use robust, reliable and sensitive detection methods for genetic testing to determine the presence of EGFR-T790m mutation-positive status in tumors or plasma samples. This is an important step to ensure the effectiveness and safety of the drug.

During the medication process, patients should follow the doctor's prescription instructions and take the medication on time and in the right amount. If you miss a dose and it is close to the next dose (for example, within 12 hours), you do not need to take the next dose as scheduled.

Patients should pay close attention to the occurrence of adverse reactions during medication, such as rash, itching, redness and swelling, difficulty breathing, etc. In the event of serious or persistent adverse reactions, you should stop taking it and seek medical advice immediately.

In the presence of congestive heart failure, electrolyte abnormalities, or use known to prolongPatients taking medications for the QTc interval should receive regular electrocardiogram (ECG) and electrolyte monitoring to ensure the safety of the medication.

Osimertinib mesylate tablets may interact with other drugs, such asCYP3A4 enzyme strong inducers and inhibitors. Therefore, use caution and seek medical advice when using these medications.